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Intermediates of the one-carbon metabolic pathway are altered in astronauts who 
experience vision-related issues during and after space flight. Serum concentrations of 
homocysteine, cystathionine, 2-methylcitric acid, and methylmalonic acid were higher in 
astronauts with ophthalmic changes than in those without (Zwart et al., J Nutr, 2012). 
These differences existed before, during, and after flight. Potential confounding factors 
did not explain the differences.  Genetic polymorphisms could contribute to these 
differences, and could help explain why crewmembers on the same mission do not all 
have ophthalmic issues, despite the same environmental factors (e.g., microgravity, 
exercise, diet). A follow-up study was conducted to evaluate 5 polymorphisms of 
enzymes in the one-carbon pathway, and to evaluate how these relate to vision and other 
ophthalmic changes after flight. Preliminary evaluations of the genetic data indicate that 
all of the crewmembers with the MTRR GG genotype had vision issues to one degree or 
another.  However, not everyone who had vision issues had this genetic polymorphism, 
so the situation is more complex than the involvement of this single polymorphism.  
Metabolomic and further data analyses are underway to clarify these findings, but the 
preliminary assessments are promising.  
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